MK-3682 PN011 A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regime of MK-5172 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT1, GT2 and GT4 Infection "C-CREST 1"
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Merck Sharp & Dohme
Start Date
February 1, 2015
End Date
December 1, 2017
Administered By
Medicine, Gastroenterology
Awarded By
Merck Sharp & Dohme
Start Date
February 1, 2015
End Date
December 1, 2017